Phase I study of LZM005 in patients with HER2-positive metastatic breast cancer.
Xue C, Li H, Yao H, Lin Y, An X, Chen M, Huang R, Li L, Hu A, Ni M, Zhang L, Yang W, Xu Z, Li S, Shi Y.
Xue C, et al. Among authors: an x.
NPJ Breast Cancer. 2022 Dec 27;8(1):132. doi: 10.1038/s41523-022-00501-2.
NPJ Breast Cancer. 2022.
PMID: 36575195
Free PMC article.